Shields Jerry A

Tailor Prashant D, Kopinski Piotr K, D'Souza Haley S, Leske David A, Olsen Timothy W, Shields Carol L et al.

Machine learning accurately predicts choroidal nevus transformation to melanoma from multimodal imaging, offering a tool to identify high-risk patients for closer monitoring.

Shukla Aakriti Garg, Vaidya Sarangdev, Yaghy Antonio, Di Nicola Maura, Kaliki Swathi, Fulco Enzo et al.

This study found that larger iris melanomas, higher initial eye pressure, advanced tumor staging, and plaque radiotherapy increase the risk of secondary glaucoma after treatment.

Yang Xiaolu, Dalvin Lauren A, Mazloumi Mehdi, Chang Michael, Shields Jerry A, Mashayekhi Arman et al.

This study found large uveal melanomas have higher risks of radiation-induced CME, NVI, and NVG after plaque radiotherapy, despite anti-VEGF, impacting prognosis.

Shields Carol L, Khoo Chloe T L, Mazloumi Mehdi, Mashayekhi Arman, Shields Jerry A

PDT for choroidal metastasis showed 78% tumor control and preserved vision in 66% of cases, making it an effective outpatient option for small-to-medium lesions.

Shields Carol L, Udyaver Sanika, Dalvin Lauren A, Lim Li-Anne S, Atalay Hatice T, Khoo Chloe et al.

This study found that more advanced stages of Coats disease are consistently linked to poorer visual acuity outcomes, emphasizing the importance of early diagnosis for better prognosis.

Shields Carol L, Say Emil A T, Fuller Timothy, Arora Saurabh, Samara Wasim A, Shields Jerry A

Retinal astrocytic hamartomas consistently originate in the nerve fiber layer, showing "moth-eaten" optically empty spaces (OES) on OCT. Larger, calcified tumors and macular location correlate with OES size/number, aiding diagnosis and understanding growth.

Samara Wasim A, Khoo Chloe T L, Say Emil Anthony T, Saktanasate Jarin, Eagle Ralph C, Shields Jerry A et al.

Ocular JXG primarily affects the iris, often isolated. Corticosteroids effectively treat iris JXG, achieving tumor regression, stable vision, and controlled eye pressure, preserving the globe.

Kaliki Swathi, Eagle Ralph C, Grossniklaus Hans E, Campbell R Jean, Shields Carol L, Shields Jerry A

Mashayekhi Arman, Shields Carol L, Shields Jerry A

This study found iris lymphoma, often high-grade, presents as steroid-resistant uveitis, frequently linked to aggressive systemic lymphoma. Consider it in middle-aged/elderly patients.

Shields Carol L, Shah Sanket U, Bianciotto Carlos G, Emrich Jacqueline, Komarnicky Lydia, Shields Jerry A

Iodine-125 plaque radiotherapy for iris melanoma showed similar recurrence, enucleation, and metastasis rates whether glaucoma was present or not, despite glaucoma cases having more diffuse tumor spread.

Sagoo Mandeep S, Shields Carol L, Mashayekhi Arman, Freire Jorge, Emrich Jacqueline, Reiff Jay et al.

Plaque radiotherapy effectively controls juxtapapillary choroidal melanoma in ~80% of cases at 10 years, with TTT offering a slight, non-significant benefit, preserving vision for these challenging tumors.

Shields Carol L, Demirci Hakan, Marr Brian P, Mashayekhi Arman, Dai Vicktoria V, Materin Miguel A et al.

Intravitreal triamcinolone for acute radiation papillopathy showed rapid resolution of optic disc edema and hyperemia, with modest visual improvement in most patients, suggesting a potential treatment for this vision-threatening complication.

Shields Jerry A, Shields Carol L, Ehya Hormoz, Dhaliwal Ranjit S

A case study showed optic nerve melanocytoma can cause total blindness, confirmed by biopsy. This highlights its potential severity and the diagnostic role of FNAB.

Demirci Hakan, Mashayekhi Arman, Shields Carol L, Eagle Ralph C, Shields Jerry A

This study on iris melanocytoma found growth and seeding are common, with glaucoma developing in 11% at 5 years. Regular monitoring is crucial due to these progressive changes.

Shields Jerry A, Demirci Hakan, Mashayekhi Arman, Shields Carol L

This study of 115 optic disc melanocytomas found they are generally benign but can cause visual loss, grow slowly, and rarely transform malignantly, necessitating periodic monitoring.

Shields Carol L, Naseripour Masood, Shields Jerry A, Freire Jorge, Cater Jacqueline

Plaque radiotherapy for nonresectable iris melanoma showed 92% tumor control at 5 years, but significant complications like cataract and elevated intraocular pressure were common, requiring careful patient counseling.

Girkin Christopher A, Goldberg Ivan, Mansberger Steven L, Shields Jerry A, Shields Carol L